Even without final approval, more than 1 million health care workers and others in China who are deemed at high risk of infection have received experimental vaccines under emergency use permission. There has been no word on possible side effects. China’s fledgling pharmaceutical industry has at least five vaccines from four producers being tested in more than a dozen countries including Russia, Egypt and Mexico.
Health experts say even if they are successful, the certification process for the United States, Europe, Japan and other developed countries might be too complex for them to be used there. However, China said it will ensure the products are affordable for developing countries. One developer, China National Pharmaceutical Group, known as Sinopharm, said in November it applied for final market approval for use of its vaccine in China. Others have been approved for emergency use on people deemed at high risk of infection. -Full Report
With world watching, Britain gets ready for mass coronavirus vaccinations
Health Ministry wants to vaccinate 2 million Israelis in six-week drive – report
Citing logistics know-how, IDF offers to aid distribution of COVID-19 vaccines
Britons back air travel ban for people who don’t receive coronavirus vaccine
